Comparable stake leader
Danny L. Dearen
SEC ownership of Axonics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001603756.
Disclosed value leader
Danny L. Dearen
Comparable rows
0/1
Latest evidence
29 Sep 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Danny L. Dearen
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
29 Sep 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001603756
- Issuer location
- Irvine, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Axonics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Danny L. Dearen
Disclosed value leader
Danny L. Dearen
Comparable rows
0/1
Latest evidence
29 Sep 2023
3/4/5
Highest disclosed value: $1,640,658
1 rows are not safely comparable across share classes.
Quick read
Danny L. Dearen has the largest disclosed position value at $1.64M.
0 of 1 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Danny L. Dearen's linked filing trail.
Disclosed position value
Top 1
Danny L. Dearen
$1.64M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-1 of 1 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Danny L. Dearen |
3/4/5
President & CFO
|
—
class O/S missing
|
$1,640,658
23,777 shares
|
— | 29 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Axonics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Largest Forms 3/4/5 holder
Danny L. Dearen
Net 12M change
$0
Latest report
15 Nov 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Danny L. Dearen | President & CFO | $1,640,658 | Mixed | 29 Sep 2023 | ||
| Ph.D John Woock | EVP, Chief Mktg/Strtgy Officer | $0 | Mixed | 15 Nov 2024 | ||
| Karen Noblett | Chief Medical Officer | $0 | Mixed | 15 Nov 2024 | ||
| Raymond W. Cohen | Chief Executive Officer, Director | $0 | Mixed | 15 Nov 2024 | ||
| Jane E. Kiernan | Director | $0 | Mixed | 15 Nov 2024 | ||
| Michael H. Carrel | Director | $0 | Mixed | 15 Nov 2024 | ||
| David M. Demski | Director | $0 | Mixed | 15 Nov 2024 | ||
| Robert McNamara | Director | $0 | Mixed | 15 Nov 2024 | ||
| Kari Leigh Keese | Chief Financial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Alfred J. Ford Jr. | Chief Commercial Officer | $0 | Mixed | 15 Nov 2024 | ||
| Esteban Lopez | Director | $0 | Mixed | 15 Nov 2024 | ||
| Rinda Sama | Chief Operating Officer | $0 | Mixed | 15 Nov 2024 | ||
| Nancy Lynn Snyderman MD | Director | $0 | Mixed | 15 Nov 2024 |
Recent insider transactions for Axonics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.